Loading...
Loading...
Shares of Somaxon Pharmaceuticals
SOMX are higher on the session by 5.88%, currently trading at $2.95. The stock has been moving largely lower over the past six months and is currently trading below the 200-day moving average.
Options traders are buying calls on the name today. A short while ago the April 2011 $3.00 call was purchased 3,000 times, on the offer, on open interest of 4,926 contracts.
Overall call volume is now running at 2.05x the daily average with 87% of all calls traded being purchases on the offer.
Somaxon Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the in-licensing and development of product candidates for the treatment of diseases and disorders in the central nervous system therapeutic area.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in